GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Cash Flow from Investing

Beijing Strong Biotechnologies (SZSE:300406) Cash Flow from Investing : ¥180 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2024, Beijing Strong Biotechnologies spent ¥39 Mil on purchasing property, plant, equipment. It gained ¥0 Mil from selling property, plant, and equipment. It spent ¥0 Mil on purchasing business. It gained ¥0 Mil from selling business. It spent ¥0 Mil on purchasing investments. It gained ¥315 Mil from selling investments. It paid ¥0Mil for net Intangibles purchase and sale. And it paid ¥0 Mil for other investing activities. In all, Beijing Strong Biotechnologies gained ¥275 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2024.


Beijing Strong Biotechnologies Cash Flow from Investing Historical Data

The historical data trend for Beijing Strong Biotechnologies's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Cash Flow from Investing Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -387.37 -1,075.95 -1,312.07 -440.82 -127.22

Beijing Strong Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.46 -123.52 -92.42 120.18 275.35

Beijing Strong Biotechnologies Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Beijing Strong Biotechnologies's Cash Flow from Investing for the fiscal year that ended in Dec. 2023 is calculated as:

Beijing Strong Biotechnologies's Cash Flow from Investing for the quarter that ended in Mar. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥180 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Strong Biotechnologies  (SZSE:300406) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Beijing Strong Biotechnologies's purchase of property, plant, equipment for the three months ended in Mar. 2024 was ¥-39 Mil. It means Beijing Strong Biotechnologies spent ¥39 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Beijing Strong Biotechnologies's sale of property, plant, equipment for the three months ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies gained ¥0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Beijing Strong Biotechnologies's purchase of business for the three months ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies spent ¥0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Beijing Strong Biotechnologies's sale of business for the three months ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies gained ¥0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Beijing Strong Biotechnologies's purchase of investment for the three months ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Beijing Strong Biotechnologies's sale of investment for the three months ended in Mar. 2024 was ¥315 Mil. It means Beijing Strong Biotechnologies gained ¥315 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Beijing Strong Biotechnologies's net Intangibles purchase and sale for the three months ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies paid ¥0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Beijing Strong Biotechnologies's cash from discontinued investing activities for the three months ended in Mar. 2024 was 0 Mil. It means Beijing Strong Biotechnologies paid ¥0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Beijing Strong Biotechnologies's cash from other investing activities for the three months ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies paid ¥0 Mil for other investing activities.


Beijing Strong Biotechnologies Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies (SZSE:300406) Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines